Trial Profile
REAL PTX - Randomized Evaluation of the Zilver PTX Stent vs. Paclitaxel-Eluting Balloons for Treatment of Symptomatic Peripheral Artery Disease of the Femoropopliteal Artery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Aspirin; Clopidogrel; Heparin
- Indications Peripheral arterial disorders; Peripheral artery restenosis
- Focus Therapeutic Use
- Acronyms REAL PTX
- 19 Feb 2019 Primary endpoint has not been met. (target lesion revascularization (TLR) (drug-eluting stents (DES) versus drug-coated balloons (DCB))), according to the results published in the Journal of the American College of Cardiology.
- 19 Feb 2019 Results published in the Journal of the American College of Cardiology
- 04 May 2015 New trial record